Brookline, MA, United States of America

Neal Gordon

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 97(Granted Patents)


Company Filing History:


Years Active: 2002-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Neal Gordon

Introduction

Neal Gordon is a prominent inventor based in Brookline, MA (US), known for his significant contributions to the field of biotechnology. With a total of five patents to his name, he has made remarkable advancements in the development of novel delivery systems for biologic agents.

Latest Patents

Among his latest patents is the invention titled "Fusosome compositions and uses thereof." This patent outlines methods and compositions for in vivo fusosome delivery, emphasizing the importance of specificity for target cells. The fusosome comprises a combination of elements, including a fusogen and regulatory elements that enhance targeting while minimizing immune responses. Another notable patent is "Compositions for facilitating membrane fusion and uses thereof," which describes fusosome compositions that facilitate the delivery of complex biologic agents directly into the target cell cytoplasm.

Career Highlights

Neal Gordon has worked with several innovative companies, including Evelo Biosciences, Inc. and Flagship Pioneering Innovations V, Inc. His work in these organizations has contributed to the advancement of biotechnological solutions that address complex medical challenges.

Collaborations

Throughout his career, Neal has collaborated with notable figures in the industry, including Noubar Boghos Afeyan and David Arthur Berry. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Neal Gordon's innovative contributions to biotechnology, particularly in the area of fusosome delivery systems, highlight his role as a leading inventor in the field. His patents and collaborations reflect a commitment to advancing medical technology and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…